UNITED OVERSEAS BANK LTD (SGX:U11)
United Overseas Bank - Boosted By Higher Net Interest Income
- UOB (SGX:U11)'s 2Q22 earnings of S$1,113mil were in line with our estimates due to higher net interest margin and healthy net interest income growth. 1H22 PATMI is 43% of our FY22e forecast.
- NII was up 18% y-o-y from a NIM increase of 11bps y-o-y to 1.67% and loan growth of 8% y-o-y. Fee income fell 1% q-o-q while other non-interest income was up 170% q-o-q. Management is guiding single-digit loan growth with higher NIMs, stable cost-to-income ratio and slightly higher provisions.
- UOB has guided NIM to expand at 9bps each quarter and to reach an exit NIM of 1.90% by the end of 2022. We estimate 2H22 NII to jump 22% y-o-y.
- Maintain BUY call on UOB with an unchanged target price of S$35.70. Our FY22e estimates remain unchanged. We assume 1.46x FY22e P/BV and ROE estimate of 11.5% in our GGM valuation. There is upside to our estimates from further GP write-backs and higher NIMs. Every 25bps rise in interest rates can raise NIM by 0.04% and PATMI by 4.3%.
The Positives
NII increased18% y-o-y, led by steady loan growth.
- NII grew 18% y-o-y, led by continued loans growth of 8% y-o-y, while NIM improved 11bps y-o-y to 1.67%. Loan growth q-o-q was mainly from term and housing loans, while y-o-y loan growth was broad-based across geographies as business regained momentum. UOB has lowered its guidance to mid single-digit loan growth for FY22e (previously mid to high single-digit).
Other non-interest income increased 170% q-o-q.
- Other NII increased 6% y-o-y due to the strong momentum for customer-related income as hedging demand rose. Other NII increased 170% q-o-q on the back of customer-related growth and normalisation from 1Q22’s short-term impact on hedges and unrealised mark-to-market on investments.
Loan fees increased 10% y-o-y.
- Fees were stable q-o-q but fell 2% y-o-y despite loan fees growth of 3% q-o-q and 10% y-o-y and record credit card fees as customer spending increased with borders reopening. However, this was partially offset by lower wealth and fund management due to subdued market conditions. UOB has lowered its guidance to low single-digit growth in fee income for FY22e (previously high single-digit growth).
The Negatives
Credit costs increased by 2bps y-o-y.
- Total allowances increased by 20% y-o-y to S$173mil resulting in credit costs increasing by 2bps y-o-y to 22bps. This was mainly due to specific allowance increasing by 20% y-o-y to S$166mil. Total general allowance for loans, including RLARs, were prudently maintained at 0.9% of performing loans. UOB has maintained its credit cost guidance of 25bps for FY22e.
New NPAs of S$661mil in 2Q22.
- New NPA formation increased by 83% y-o-y and 43% q-o-q to S$661mil mainly due to a major but non-systemic corporate account. Resultantly, the NPL ratio rose by 0.1% to 1.7%. Nonetheless, asset quality remained resilient with SP/NPA stable at 30%. 2Q22 NPA coverage is at 91% and unsecured NPA coverage at 185%.
Outlook
PATMI:
- UOB’s profit should continue to grow in 2022e on the back of stabilising margins, stronger fees and lower provisions. We expect NII to expand 14% y-o-y. We expect credit costs to come in below guidance of 25bps.
- Management has said that as it is being conservative, they are not intending to write-back provisions but will not be adding a significant amount during the second half of 2022.
NIMs:
- Management expects improvement in NIMs only in the later part of 2022. They are expecting NIM to sustain growth at 9bps each quarter and to reach 1.90% by the end of 2022. UOB said that a 25bps rise in interest rates could raise NII by $150mil-200mil (or NIM sensitivity of 4bps for every 25bps rate hike).
- Assuming rate hikes totalling 100bps this year, our FY22e NII can climb S$800mil (or 11%) resulting in an increase in our FY22e PATMI by 17%.
Loan growth:
- UOB's management expects to see strong demand for loans as cross-border activities pick up. ASEAN loans growth is expected to be higher with some slowdown in Singapore and North Asia. Growth so far has been skewed towards the developed markets as the ASEAN economy remains muted, but management expects this to change in 2022 as the economy recovers. UOB has guided mid single-digit loan growth for FY22e.
China exposure:
- UOB’s mainland China exposure stands at S$24.8bn or 5% of total assets, of which S$8.2bn is bank exposure and S$12.6bn is non-bank exposure. The top 5 domestic banks and 3 policy banks account for ~70% of total bank exposure while non-bank exposure’s client base include top-tier state-owned enterprises, large local corporates and foreign investment enterprises.
- Management has mentioned they have ~S$3bn in loans to mainland Chinese developers (1% of group loans) with low borrower concentration and they do not see any risk of it turning to NPL.
Maintain BUY with unchanged target price of S$35.70.
- We maintain our BUY recommendation on UOB with an unchanged target price of S$35.70. Our FY22e estimates remain unchanged. We assume 1.46x FY22e P/BV and ROE estimate of 11.5% in our GGM valuation.
- See
Glenn Thum
Phillip Securities Research
|
https://www.stocksbnb.com/
2022-08-01
SGX Stock
Analyst Report
35.700
SAME
35.700
